Research programme: PCSK 9 inhibitors - Pfizer/ University of Queensland Institute for Molecular BioscienceAlternative Names: PCSK 9 vaccine - Pfizer
Latest Information Update: 02 Mar 2015
At a glance
- Originator Pfizer; University of Queenslands Institute for Molecular Bioscience
- Class Peptides; Small molecules; Vaccines
- Mechanism of Action PCSK9 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders; Lipid metabolism disorders